Points of recombination in Epstein-Barr virus (EBV) strain P3HR-1-derived heterogeneous DNA as indexes to EBV DNA recombinogenic events in vivo

Journal of Virology

Volumn 82, Issue 23, 2008, Pages 11516-11525

  Ikuta, Kazufumi ^a,d   Srinivas, Shamala K ^b,e   Schacker, Tim ^c,f   Miyagi, Jun Ichi ^a   Scott, Rona S ^a   Sixbey, John W ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

^f UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; VIRUS DNA;

ARTICLE; CONTROLLED STUDY; DNA RECOMBINATION; EPSTEIN BARR VIRUS; GENE DELETION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IN VIVO STUDY; LYMPHOMA CELL; LYMPHOMA CELL LINE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRUS GENOME; VIRUS REACTIVATION; VIRUS RECOMBINATION; VIRUS REPLICATION; VIRUS STRAIN;

CELL LINE; DNA, VIRAL; HERPESVIRUS 4, HUMAN; HIV INFECTIONS; HUMANS; POLYMERASE CHAIN REACTION; RECOMBINATION, GENETIC; VIRUS ACTIVATION; VIRUS REPLICATION;

EPSTEIN-BARR VIRUS STRAIN P3HR-1; HUMAN HERPESVIRUS 4; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 56449111100     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01036-08     Document Type: Article

References (47)

1. Alfieri, C., M. Birkenback, and E. Kieff. 1991. Early events in Epstein-Barr virus infection of human B lymphocytes. Virology 181:595-608.
2. Baer, R. J., A. T. Bankier, M. D. Biggin, P. L. Deininger, P. J. Farrell, T. J. Gibson, G. F. Hatfull, G. S. Hudson, S. C. Satchwell, C. Seguin, P. S. Tuffnell, and B. G. Barrell. 1984. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310:207-211.
3. Bornkamm, G. W., H. Delius, U. Zimber, J. Hudewentz, and M. A. Epstein. 1980. Comparison of Epstein-Barr virus strains of different origin by analysis of the viral DNAs. J. Virol. 35:603-618.
4. Bornkamm, G. W., J. Hudewentz, U. K. Freese, and U. Zimber. 1982. Deletion of the nontransforming Epstein-Barr virus strain P3HR-1 causes fusion of the large internal repeat to the DSL region. J. Virol. 43:952-968.
5. Cho, M. S., G. W. Bornkamm, and H. Zur Hausen. 1984. Structure of defective DNA molecules in Epstein-Barr virus preparations from P3HR-1 cells. J. Virol. 51:199-207.
6. Cho, M. S., L. Gissman, and S. D. Hayward. 1984. Epstein-Barr virus (P3HR-1) defective DNA codes for components of both the early antigen and viral capsid antigen complexes. Virology 137:9-19.
7. Decker, L. L., L. D. Klaman, and D. A. Thorley-Lawson. 1996. Detection of the latent form of Epstein-Barr virus DNA in the peripheral blood of healthy individuals. J. Virol. 70:3286-3289.
8. Delius, H., and G. W. Bornkamm. 1978. Heterogeneity of Epstein-Barr virus. III. Comparison of a transforming and a nontransforming virus by partial denaturation mapping of their DNAs. J. Virol. 27:81-89.
9. Dolan, A., C. Addison, D. Gatherer, A. J. Davidson, and D. J. McGeoch. 2006. The genome of Epstein-Barr virus type 2 strain AG876. Virology 350:164-170.
10. Gan, Y. J., B. I. Razzouk, T. Su, and J. W. Sixbey. 2002. A defective, rearranged Epstein-Barr virus genome in EBER-negative and EBER-positive Hodgkin's disease. Am. J. Pathol. 160:781-786.
11. Gardella, T., P. Medveczky, T. Sairenji, and C. Mulder. 1984. Detection of circular and linear herpesvirus DNA molecules in mammalian cells by gel electrophoresis. J. Virol. 50:248-254.
12. Geser, A., G. de The, G. Lenoir, N. E. Day, and E. H. Williams. 1982. Final case reporting from the Ugandan prospective study of the relationship between EBV and Burkitt's lymphoma. Int. J. Cancer 29:397-400.
13. Gilligan, K., P. Rajadurai, L. Resnick, and N. Raab-Traub. 1990. Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia. Proc. Natl. Acad. Sci. USA 87:8790-8794.
14. Heller, M., T. Dambaugh, and E. Kieff. 1981. Epstein-Barr virus DNA. IX. Variation among viral DNAs from producer and nonproducer infected cells. J. Virol. 38:632-648.
15. Heston, L., M. Rabson, N. Brown, and G. Miller. 1982. New Epstein-Barr virus variants from cellular subclones of P3J-HR-1 Burkitt lymphoma. Nature 295:160-163.
16. Hinuma, Y., M. Konn, J. Yamaguchi, D. J. Wudarski, J. R. Blakeslee, Jr., and J. T. Grace. 1967. Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line. J. Virol. 1:1045-1051.
17. Jackson, S. A., and N. A. DeLuca. 2003. Relationship of herpes simplex virus genome configuration to productive and persistent infections. Proc. Natl. Acad. Sci. USA 100:7871-7876.
18. Jenson, H. B., and G. Miller. 1988. Polymorphisms of the region of the Epstein-Barr virus genome which disrupts latency. Virology 165:549-564.
19. Jenson, H. B., M. S. Rabson, and G. Miller. 1986. Palindromic structure and polypeptide expression of 36 kilobase pairs of heterogeneous Epstein-Barr virus (P3HR-1) DNA. J. Virol. 58:475-486.
20. Jenson, H. B., P. J. Farrell, and G. Miller. 1987. Sequences of the Epstein-Barr virus (EBV) large internal repeat form the center of a 16-kilobase palindrome of EBV (P3HR-1) heterogeneous DNA. J. Virol. 61:1495-1506.
21. Kelly, B. G., S. K. Lok, P. S. Hasleton, J. J. Egan, and J. P. Stewart. 2002. A rearranged form of Epstein-Barr virus DNA is associated with idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 166:510-513.
22. Kelly, G., A. Bell, and A. Rickinson. 2002. Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2. Nat. Med. 8:1098-1104.
23. Kelly, G. L., A. E. Miller, R. J. Tierney, D. S. G. Croom-Carter, M. Altmann, W. Hammerschmidt, A. J. Bell, and A. B. Rickinson. 2005. Epstein-Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A, -3B, and -3C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis. J. Virol. 79:10709-10717.
24. King, W., T. Dambaugh, M. Heller, J. Dowling, and E. Kieff. 1982. Epstein-Barr virus DNA. XII. A variable region of the Epstein-Barr virus genome is included in the P3HR-1 deletion. J. Virol. 43:979-986.
25. Kolman, J. L., C. J. Kolman, and G. Miller. 1992. Marked variation in the size of genomic plasmids among members of a family of related Epstein-Barr viruses. Proc. Natl. Acad. Sci. USA 89:7772-7776.
26. Laichalk, L. L., and D. A. Thorley-Lawson. 2005. Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J. Virol. 79:1296-1307.
27. Levine, P. H., G. Stemmermann, E. T. Lennette, A. Hildesheim, D. Shibata, and A. Nomura. 1995. Elevated antibody titers to Epstein-Barr virus prior to the diagnosis of Epstein-Barr virus-associated gastric adenocarcinoma. Int. J. Cancer 60:642-644.
28. Miller, G., L. Heston, and J. Countryman. 1985. P3HR-1 Epstein-Barr virus with heterogeneous DNA is an independent replicon maintained by cell-to-cell spread. J. Virol. 54:45-52.
29. Miller, G., M. Rabson, and L. Heston. 1984. Epstein-Barr virus with heterogeneous DNA disrupts latency. J. Virol. 50:174-182.
30. Mueller, N., A. Evans, N. L. Harris, G. W. Comstock, E. Jellum, K. Magnus, N. Orentreich, B. F. Polk, and J. Vogelman. 1989. Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis. N. Engl. J. Med. 320:689-695.
31. Mueller, N., A. Mohar, A. Evans, N. L. Harris, G. W. Comstock, E. Jellum, K. Magnus, N. Orentreich, P. F. Polk, and J. Vogelman. 1991. Epstein-Barr virus antibody patterns preceding the diagnosis of non-Hodgkin's lymphoma. Int. J. Cancer 49:387-393.
32. Nuebling, C. M., and N. Mueller-Lantzch. 1989. Identification and characterization of an Epstein-Barr virus early antigen that is encoded by the NotI repeats. J. Virol. 63:4609-4615.
33. Nuebling, C. M., and N. Mueller-Lantzch. 1991. Identification of the gene product encoded by PstI repeats (IR4) of the Epstein-Barr virus genome. Virology 185:519-523.
34. Parker, B. D., A. Bankier, S. Satchwell, B. Barrell, and P. J. Farrell. 1990. Sequence and transcription of Raji Epstein-Barr virus DNA spanning the B95-8 deletion region. Virology 179:339-346.
35. Patton, D. F., P. Shirley, N. Raab-Traub, L. Resnick, and J. W. Sixbey. 1990. Defective viral DNA in Epstein-Barr virus-associated oral hairy leukoplakia. J. Virol. 64:397-400.
36. Patton, D. F., R. C. Ribeiro, J. J. Jenkins, and J. W. Sixbey. 1994. Thymic carcinoma with a defective Epstein-Barr virus encoding the BZLF1 trans-activator. J. Infect. Dis. 170:7-12.
37. Rabson, M., L. Gradoville, L. Heston, and G. Miller. 1982. Non-immortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye. J. Virol. 44:834-844.
38. Rabson, M., L. Heston, and G. Miller. 1983. Identification of a rare Epstein-Barr virus variant that enhances early antigen expression in Raji cells. Proc. Natl. Acad. Sci. USA 80:2762-2766.
39. Razzouk, B. I., S. Srinivas, C. E. Sample, V. Singh, and J. W. Sixbey. 1996. Epstein-Barr virus DNA recombination and loss in sporadic Burkitt's lymphoma. J. Infect. Dis. 173:529-535.
40. Rooney, C., N. Taylor, J. Countryman, H. Jenson, J. Kolman, and G. Miller. 1988. Genome rearrangements activate the Epstein-Barr virus gene whose product disrupts latency. Proc. Natl. Acad. Sci. USA 85:9801-9805.
41. Shinkura, R., N. Yamamoto, C. Koriyama, Y. Shinmura, Y. Eizuru, and M. Tokunaga. 2000. Epstein-Barr virus-specific antibodies in Epstein-Barr virus-positive and -negative gastric carcinoma cases in Japan. J. Med. Virol. 60: 411-416.
42. Sixbey, J. W., P. Shirley, M. Sloas, N. Raab-Traub, and V. Israele. 1991. A transformation-incompetent, nuclear antigen 2-deleted Epstein-Barr virus associated with replicative infection. J. Infect. Dis. 163:1008-1015.
43. Walling, D. M., S. E. Edmiston, J. W. Sixbey, M. Abdel-Hamid, L. Resnick, and N. Raab-Traub. 1992. Coinfection with multiple strains of the Epstein-Barr virus in human immunodeficiency virus-associated hairy leukoplakia. Proc. Natl. Acad. Sci. USA 89:6560-6564.
44. Xue, S.-A., L. G. Labrecque, Q.-L. Lu, S. K. Ong, I. A. Lampert, P. Kazembe, P. Molyneux, R. L. Broadhead, E. Borgstein, and B. E. Griffin. 2002. Promiscuous expression of Epstein-Barr virus genes in Burkitt's lymphoma from the central African country, Malawi. Int. J. Cancer 99:635-643.
45. Xue, S.-A., M. D. Jones, Q.-L. Lu, J. M. Middeldorp, and B. E. Griffin. 2003. Genetic diversity: frameshift mechanisms alter coding of a gene (Epstein-Barr virus LF3 gene) that contains multiple 102-base-pair direct sequence repeats. Mol. Cell. Biol. 23:2192-2201.
46. Xue, S.-A., Q.-L. Lu, R. Poulsom, L. Karran, M. D. Jones, and B. E. Griffin. 2000. Expression of two related early genes in Epstein-Barr virus-associated tumors. J. Virol. 74:2793-2803.
47. Zeng, Y., L. G. Zhang, Y. C. Wu, Y. S. Huang, N. Q. Huang, J. Y. Li, Y. B. Wang, M. K. Jiang, Z. Fang, and N. N. Meng. 1985. Prospective studies on nasopharyngeal carcinoma in Epstein-Barr virus IgA/VCA antibody-positive persons in Wuzhou City, China. Int. J. Cancer 36:545-547.